Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Effects of size at birth, childhood growth patterns and growth hormone treatment on leukocyte telomere length.

Smeets CC, Codd V, Denniff M, Samani NJ, Hokken-Koelega AC.

PLoS One. 2017 Feb 8;12(2):e0171825. doi: 10.1371/journal.pone.0171825. eCollection 2017.

2.

Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review.

Sever S, White DL, Garcia JM.

Endocr Relat Cancer. 2016 Sep;23(9):R393-409. doi: 10.1530/ERC-16-0130. Review.

3.

Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study.

Cappa M, Iughetti L, Loche S, Maghnie M, Vottero A; GeNeSIS National Board on behalf of the GeNeSIS Italian Investigators.

J Endocrinol Invest. 2016 Jun;39(6):667-77. doi: 10.1007/s40618-015-0418-0. Epub 2015 Dec 28.

4.

Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone.

Swerdlow AJ, Cooke R, Albertsson-Wikland K, Borgström B, Butler G, Cianfarani S, Clayton P, Coste J, Deodati A, Ecosse E, Gausche R, Giacomozzi C, Kiess W, Hokken-Koelega AC, Kuehni CE, Landier F, Maes M, Mullis PE, Pfaffle R, Sävendahl L, Sommer G, Thomas M, Tollerfield S, Zandwijken GR, Carel JC.

Horm Res Paediatr. 2015;84(3):172-83. doi: 10.1159/000435856. Epub 2015 Jul 23.

5.

Medication Exposures and Subsequent Development of Ewing Sarcoma: A Review of FDA Adverse Event Reports.

Cope JU, Reaman GH, Tonning JM.

Sarcoma. 2015;2015:948159. doi: 10.1155/2015/948159. Epub 2015 May 7. Review.

6.

A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature.

Rothenbuhler A, Linglart A, Bougnères P.

Int J Pediatr Endocrinol. 2015;2015(1):4. doi: 10.1186/1687-9856-2015-4. Epub 2015 Feb 16. Erratum in: Int J Pediatr Endocrinol. 2017;2017:4.

7.

Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.

Raman S, Grimberg A, Waguespack SG, Miller BS, Sklar CA, Meacham LR, Patterson BC.

J Clin Endocrinol Metab. 2015 Jun;100(6):2192-203. doi: 10.1210/jc.2015-1002. Epub 2015 Apr 3. Review.

8.

In vivo investigations of the effect of short- and long-term recombinant growth hormone treatment on DNA-methylation in humans.

Kolarova J, Ammerpohl O, Gutwein J, Welzel M, Baus I, Riepe FG, Eggermann T, Caliebe A, Holterhus PM, Siebert R, Bens S.

PLoS One. 2015 Mar 18;10(3):e0120463. doi: 10.1371/journal.pone.0120463. eCollection 2015.

9.

Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.

Petryk A, Kanakatti Shankar R, Giri N, Hollenberg AN, Rutter MM, Nathan B, Lodish M, Alter BP, Stratakis CA, Rose SR.

J Clin Endocrinol Metab. 2015 Mar;100(3):803-11. doi: 10.1210/jc.2014-4357. Epub 2015 Jan 9. Review.

10.

Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis.

Locatelli V, Bianchi VE.

Int J Endocrinol. 2014;2014:235060. doi: 10.1155/2014/235060. Epub 2014 Jul 23. Review.

11.

Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit.

Sotos JF, Tokar NJ.

Int J Pediatr Endocrinol. 2014;2014(1):15. doi: 10.1186/1687-9856-2014-15. Epub 2014 Jul 16.

12.

Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerations.

Cohen P, Weng W, Rogol AD, Rosenfeld RG, Kappelgaard AM, Germak J.

Clin Endocrinol (Oxf). 2014 Jul;81(1):71-6. doi: 10.1111/cen.12408. Epub 2014 Feb 7.

14.

Function of matrix IGF-1 in coupling bone resorption and formation.

Crane JL, Cao X.

J Mol Med (Berl). 2014 Feb;92(2):107-15. doi: 10.1007/s00109-013-1084-3. Epub 2013 Sep 26. Review.

15.

Growth Hormone and Treatment Controversy; Long Term Safety of rGH.

Divall SA, Radovick S.

Curr Pediatr Rep. 2013 Jun 1;1(2):128-132.

16.

Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee.

Adatia I, Haworth SG, Wegner M, Barst RJ, Ivy D, Stenmark KR, Karkowsky A, Rosenzweig E, Aguilar C.

Pulm Circ. 2013 Jan;3(1):252-66. doi: 10.4103/2045-8932.109931.

17.

The variability of responses to growth hormone therapy in children with short stature.

Savage MO, Bang P.

Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S178-84. doi: 10.4103/2230-8210.104034.

18.

GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.

Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS; 2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants.

J Clin Endocrinol Metab. 2013 Jun;98(6):E1072-87. doi: 10.1210/jc.2012-3888. Epub 2013 Mar 29. Review.

19.

Childhood stunting and mortality between 36 and 64 years: the British 1946 Birth Cohort Study.

Ong KK, Hardy R, Shah I, Kuh D; National Survey of Health and Development Scientific and Data Collection Teams.

J Clin Endocrinol Metab. 2013 May;98(5):2070-7. doi: 10.1210/jc.2012-3595. Epub 2013 Mar 26.

20.

Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients.

Hartman ML, Xu R, Crowe BJ, Robison LL, Erfurth EM, Kleinberg DL, Zimmermann AG, Woodmansee WW, Cutler GB Jr, Chipman JJ, Melmed S; International HypoCCS Advisory Board.

J Clin Endocrinol Metab. 2013 Mar;98(3):980-8. doi: 10.1210/jc.2012-2684. Epub 2013 Jan 23.

Supplemental Content

Support Center